Mandate

Vinge advises Embellence Group AB (publ) in connection with the listing on Nasdaq First North Premier Growth Market

Vinge advises Embellence Group AB (publ) (“Embellence Group”) in connection with the listing on Nasdaq First North Premier Growth Market. The offering circular was published on 15 March 2021 and first day of trading was on 24 March 2021.

The offering price was SEK 42, corresponding to a market value of Embellence Group of approximately SEK 900 million. The offering comprised approximately 10.8 million shares, corresponding to a value of approximately SEK 454 million, provided that the overallotment option is exercised in its entirety.

Embellence Group, founded in 1905 in Borås, Sweden, is a leding European company in interior decoration, with a focus on premium brands within wallpaper, textile, rugs and other interior decoration with sales in over 90 countries. The company’s brand portfolio includes Cole & Son, Wall&decò, Perswall, Pappelina and Boråstapeter.

Vinge’s team mainly consisted of Johan Winnerblad, Jesper Schönbeck, Rikard Lindahl, Joel Magnusson, Linnea Petersson and Louise Brorsson Salomon, Pauline Lagerstrand and Rebecka Målquist regarding financing matters and Mattias Schömer and Henrik Wastenson regarding tax matters.

 

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026